Prescribing Information for ▼PAXLOVID (nirmatrelvir / ritonavir) can be found here. Adverse event reporting information can be found at the bottom of the page.
Paxlovid has a Conditional Marketing Authorisation in the United Kingdom. A Conditional Marketing Authorisation means that further evidence on this medicinal product is awaited. New information on this medicinal product will be reviewed when any relevant information of significance becomes available and at least every year and the product information will be updated as necessary.
Intended for UK HCPs only.
Search
A search identifying individual cohorts of patients at the highest risk of severe COVID-19 as defined in line with NICE recommendations
Alert
Sends a real-time notification to clinicians when a high risk patient's record is opened and a consultation started, informing HCPs that the patient may be at risk of severe COVID-19 progression.
Refer
A referral form that sits within the clinical system and includes a number of fields that will pre-populate with the patient's information and medical summary. This may make it easier for clinicians to refer high-risk patients for COVID-19 treatment services for review of their eligibility or treatment.
These resources may support you with:
Why is it important to identify and communicate with high-risk patients?
These tools and supporting materials should not be used to replace clinical, medical judgement, advice, diagnosis or treatment of any health condition. Each patient should be individually assessed for the most appropriate course of action. Refer to the relevant SmPC and local or national guidance to support decision making.
References:
3. Data on file. Pfizer Inc. Excerpts from Full Clinical Study Report for EPIC-HR and Core Data Sheet. February 2024.
Adverse Events
Adverse Events should be reported. Reporting forms and information can be found at https://coronavirus-yellowcard.mhra.gov.uk/ or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2025 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-UNP-GBR-7812. January 2024.